Clinical Application and Potential of Cognitive Amyloid Risk Measure: James Galvin, MD, MPH
June 4, 2025
News article and an explanatory video published on NeurologyLive. In it, Dr. James Galvin, MD, MPH, Chief Scientific Officer at Cognivue, gives an informative explanation of the clinical application of Cognivue’s new prediction metric, the Cognivue Amyloid Risk Measure (CARM).*
*patent pending
